ConductScience.org, home

Paper · 37726484

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135,772,405Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.Cell2022https://conductscience.org/library/papers/35772405PubMed
235,438,546An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses.Sci Transl Med2022https://conductscience.org/library/papers/35438546PubMed
334,537,245Structures of synthetic nanobody-SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction.J Biol Chem2021https://conductscience.org/library/papers/34537245PubMed
433,169,668Biochemical patterns of antibody polyreactivity revealed through a bioinformatics-based analysis of CDR loops.Elife2020https://conductscience.org/library/papers/33169668PubMed
533,756,110The antigenic anatomy of SARS-CoV-2 receptor binding domain.Cell2021https://conductscience.org/library/papers/33756110PubMed
632,225,175Structural basis of receptor recognition by SARS-CoV-2.Nature2020https://conductscience.org/library/papers/32225175PubMed
734,554,826Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study.Science2021https://conductscience.org/library/papers/34554826PubMed
826,193,119Contacts-based prediction of binding affinity in protein-protein complexes.Elife2015https://conductscience.org/library/papers/26193119PubMed
934,244,522Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.Nat Commun2021https://conductscience.org/library/papers/34244522PubMed
105,551,392The interpretation of protein structures: estimation of static accessibility.J Mol Biol1971https://conductscience.org/library/papers/5551392PubMed
112,687,698Conformations of immunoglobulin hypervariable regions.Nature1989https://conductscience.org/library/papers/2687698PubMed
1232,661,058Structural basis of a shared antibody response to SARS-CoV-2.Science2020https://conductscience.org/library/papers/32661058PubMed
1336,085,335Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models.Commun Biol2022https://conductscience.org/library/papers/36085335PubMed
1437,261,904Modeling of ACE2 and antibodies bound to SARS-CoV-2 provides insights into infectivity and immune evasion.JCI Insight2023https://conductscience.org/library/papers/37261904PubMed
152,454,644Three-dimensional structure of antibodies.Annu Rev Immunol1988https://conductscience.org/library/papers/2454644PubMed
1628,588,190An optimal distance cutoff for contact-based Protein Structure Networks using side-chain centers of mass.Sci Rep2017https://conductscience.org/library/papers/28588190PubMed
1736,535,326Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution.Nature2023https://conductscience.org/library/papers/36535326PubMed
1834,155,209Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain.Nat Commun2021https://conductscience.org/library/papers/34155209PubMed
1937,023,193Germline-encoded amino acid-binding motifs drive immunodominant public antibody responses.Science2023https://conductscience.org/library/papers/37023193PubMed
2035,412,617Search and sequence analysis tools services from EMBL-EBI in 2022.Nucleic Acids Res2022https://conductscience.org/library/papers/35412617PubMed

papers-2026-11-12-0.1.0

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/papers/v1/37726484/references